Search details
1.
A large deletion in a non-coding regulatory region leads to NFKB1 haploinsufficiency in two adult siblings.
Clin Immunol
; 261: 110165, 2024 04.
Article
in English
| MEDLINE | ID: mdl-38423196
2.
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
Ann Rheum Dis
; 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38777378
3.
Clinical, Radiologic, and Immunologic Features of Patients With CTLA4 Deficiency With Neurologic Involvement.
Neurology
; 101(15): e1560-e1566, 2023 10 10.
Article
in English
| MEDLINE | ID: mdl-37487754
4.
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.
J Immunother Cancer
; 11(5)2023 05.
Article
in English
| MEDLINE | ID: mdl-37258037
5.
Sjögren syndrome overlapping with ANCA-associated vasculitis: Four additional cases and systematic literature review.
Autoimmun Rev
; 21(6): 103099, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35452855
6.
Underreporting of Major Cardiac Adverse Events With Immune Checkpoint Inhibitors in Clinical Trials: Importance of Postmarketing Pharmacovigilance Surveys.
J Clin Oncol
; 41(5): 1154-1156, 2023 02 10.
Article
in English
| MEDLINE | ID: mdl-36318740
7.
Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye!
Eur J Cancer
; 177: 194-196, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36809166
8.
Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis.
Eur J Cancer
; 155: 25-27, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34332401
Results
1 -
8
de 8
1
Next >
>>